COAVE THERAPEUTICS
Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
COAVE THERAPEUTICS
Social Links:
Industry:
Biotechnology Genetics Life Science Neuroscience
Founded:
2014-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.coavetx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
79.1 M EUR
Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail Person Schema OVH OVH DNS
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Cognition Therapeutics
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Verve Therapeutics
Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
GO CAPITAL
GO CAPITAL investment in Series B - Coave Therapeutics
Seroba Life Sciences
Seroba Life Sciences investment in Series B - Coave Therapeutics
Omnes Capital
Omnes Capital investment in Series B - Coave Therapeutics
Kurma Partners
Kurma Partners investment in Series B - Coave Therapeutics
Sham Innovation Santé
Sham Innovation Santé investment in Series B - Coave Therapeutics
V-Bio Ventures
V-Bio Ventures investment in Series B - Coave Therapeutics
Idinvest Partners
Idinvest Partners investment in Series B - Coave Therapeutics
V-Bio Ventures
V-Bio Ventures investment in Series B - Coave Therapeutics
GO CAPITAL
GO CAPITAL investment in Series B - Coave Therapeutics
Sham Innovation Santé
Sham Innovation Santé investment in Series B - Coave Therapeutics
Key Employee Changes
Official Site Inspections
http://www.coavetx.com Semrush global rank: 5.86 M Semrush visits lastest month: 1.42 K
- Host name: cluster028.hosting.ovh.net
- IP address: 51.91.236.193
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Coave Therapeutics"
Coave Therapeutics – Coave Therapeutics is a clinical stage ...
ABL is a pure play contract development and manufacturing organization (CDMO) specialized in the development and manufacturing of viral vectors for vaccine candidates, gene and cancer …See details»
Coave Therapeutics and ABL enter into strategic collaboration to ...
Jun 9, 2022 For more information, please visit www.coavetx.com or follow us on LinkedIn About ABL, an Institut Mérieux company ABL is a pure play contract development and manufacturing …See details»
Coave Therapeutics Receives Grant from the ALS Association
Feb 29, 2024 The ALS Association is the largest ALS organization in the world. The ALS Association funds global research collaborations, assists people with ALS and their families …See details»
Coave Therapeutics - Crunchbase Company Profile
Organization. Coave Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Coave Therapeutics is active in the field of gene …See details»
Coave Therapeutics - LinkedIn
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases.See details»
Coave Therapeutics and ABL enter into strategic collaboration to ...
Organization (CDMO) specialized in the development and manufacturing of viruses for vaccine candidates, gene and cancer therapies, today announce that they have entered into a …See details»
Coave Therapeutics - Drug pipelines, Patents, Clinical …
2 days ago CONTACTS Coave Therapeutics Rodolphe Clerval, CEO [email protected] MEDiSTRAVA Sylvie Berrebi, Leila Adlam, Mark Swallow [email protected] . Clinical Study. 100 Deals associated with Coave …See details»
Coave Therapeutics Receives Grant from the ALS Association to …
Paris, France, February 29 th, 2024 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies, is delighted to announce that it is one of six …See details»
Coave Therapeutics Company Overview, Contact Details
[email protected]: [email protected]: 6%. See more formats. Frequently Asked Questions Where is Coave Therapeutics 's headquarters located? Coave Therapeutics 's main …See details»
Coave Therapeutics Receives Grant from the ALS Association to …
Feb 29, 2024 CTx-TFEB is a novel, targeted genetic medicine approach designed to promote autophagy and reduce the accumulation of toxic protein aggregates in neurons Funding aims …See details»
CTx-TFEB - Drug Targets, Indications, Patents - Synapse - Patsnap
Neurotox Res (2018) Jul;34(1):109-120 About the ALS AssociationThe ALS Association is the largest ALS organization in the world. The ALS Association funds global research …See details»
Coave Therapeutics to Present Novel Data Highlighting the …
Paris, France, September 24, 2024 – Coave Therapeutics (‘Coave’), a genetic medicine company pioneering therapies for eye and neurodegenerative diseases, will present the first data on its ...See details»
Coave Therapeutics and ABL enter into strategic collaboration to ...
Jun 9, 2022 For more information, please visit www.coavetx.com or follow us on LinkedIn . About ABL, an Institut Mérieux company. ABL is a pure play contract development and …See details»
Coave Therapeutics announces Positive 12-months Data from …
May 31, 2023 Coave Therapeutics. CTx-PDE6b demonstrated clinically meaningful benefit in visual functions at the highest dose and exhibits a good safety profile . Positive results from …See details»
Coave Therapeutics Receives Grant from the ALS Association
Feb 29, 2024 The ALS Association is the largest ALS organization in the world. The ALS Association funds global research collaborations, assists people with ALS and their families …See details»
COAVE THERAPEUTICS AND ABL ENTER INTO STRATEGIC …
Jun 9, 2022 For more information, please visit www.coavetx.com or follow us on LinkedIn About ABL, an Institut Mérieux company ABL is a pure play contract development and manufacturing …See details»
Coave Therapeutics - Overview, News & Similar companies
Www.coavetx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Coave wins grant to advance gene therapy CTx-TFEB for ALS - ... Mar …See details»
240229 Coave - ALS grant PR Final - coavetx.com
The ALS Association is the largest ALS organization in the world. The ALS Association funds global research collaborations, assists people with ALS and their families through its U.S. …See details»
Coave Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Coave Therapeutics Strengthens Leadership Team with the …
Paris, France, 15 th November 2021 – Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies in rare Ocular …See details»